[6] In the 1990s, Darnytsia began to re-equip production in accordance with the requirements of the GMP (Good Manufacturing Practice) standard.

[7] By 2010, according to a study by O. Posylkina and M. Sidorenko, the company was ahead of other Ukrainian enterprises, having certified 5 sites where 112 different drugs were produced.

In 2000, the system for obtaining drinking-quality water was reconstructed, in 2002, a new plant of sterile cephalosporin antibiotics was launched, in 2012, the ampoule production was re-equipped.

[11][12] According to research by Mykola Grebnev and Inna Vinnikova, by 2009 the company had a production area of more than 30 thousand square meters.

[18] According to Natalia Tkachenko, in 2012, Darnytsia was among the top three companies in terms of disclosure of information on corporate social responsibility (among the 20 largest pharmaceutical manufacturers in Ukraine).

Among the philanthropic projects, university scholarships were funded for ₴3.4 million, a study of public issues and educational activities of The Aspen Institute Kyiv was funded for ₴1 million, as well as scholarships for participants in the Petro Jacyk International Competition for Experts in the Ukrainian Language.

Social programs and projects were funded, in particular, "З турботою про співвітчизника" ("Taking care of a compatriot"), #GivingTuesday, "Твій безмежний світ" ("Your boundless world").